Martin Fan 's Stock Ratings

Wedbush Analyst

Martin Fan is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

73.0%

Smart Score

77.9%

Overall Average Return Percentile

97th

Number of Ratings

15
Buy NowGet Alert
11/25/2025VORBuy Now
Vor Biopharma
$13.28-32.25% → $9Assumes → NeutralGet Alert
11/25/2025IMABuy Now
ImageneBio
$6.34-68.45% → $2Assumes → UnderperformGet Alert
11/24/2025ANABBuy Now
AnaptysBio
$44.2213.08%$50 → $50ReiteratesOutperform → OutperformGet Alert
11/07/2025SANABuy Now
Sana Biotechnology
$5.1117.42%$5 → $6MaintainsOutperformGet Alert
10/17/2025ARTVBuy Now
Artiva Biotherapeutics
$5.13348.78%$18 → $23MaintainsOutperformGet Alert
10/09/2025ZBIOBuy Now
Zenas BioPharma
$34.9814.35%$35 → $40MaintainsOutperformGet Alert
09/30/2025ANABBuy Now
AnaptysBio
$44.221.78%$45 → $45ReiteratesOutperform → OutperformGet Alert
09/24/2025SANABuy Now
Sana Biotechnology
$5.11-2.15% → $5Initiates → OutperformGet Alert
08/07/2025ANABBuy Now
AnaptysBio
$44.221.78%$40 → $45MaintainsOutperformGet Alert
07/09/2025RNACBuy Now
Cartesian Therapeutics
$8.67338.17% → $38Initiates → OutperformGet Alert
05/28/2025ACRSBuy Now
Aclaris Therapeutics
$3.21148.83% → $8Initiates → OutperformGet Alert
05/15/2025ORKABuy Now
Oruka Therapeutics
$30.3131.97%$40 → $40ReiteratesOutperform → OutperformGet Alert
05/01/2025ANABBuy Now
AnaptysBio
$44.22-9.53%$40 → $40ReiteratesOutperform → OutperformGet Alert
03/25/2025ARTVBuy Now
Artiva Biotherapeutics
$5.13251.22%$18 → $18ReiteratesOutperform → OutperformGet Alert
03/20/2025ZBIOBuy Now
Zenas BioPharma
$34.980.06% → $35Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free